At the Benzinga Cannabis Capital Conference in Florida, Cresco Labs’ (OTCQX: CRLBF) CEO Charlie Bachtell shared optimistic views on cannabis rescheduling, emphasizing the importance of the process it’s undergoing. “This is going through the process it needs to… it’s a matter of when,” Bachtell highlighted, underscoring the significance of Health and Human Services’ acknowledgment of cannabis’ medicinal value—a monumental step for the industry. The Political Landscape And SAFER BankingWith a presidential election on the horizon, Bachtell discussed the political implications of rescheduling ca…